Wilbanks Smith & Thomas Asset Management’s Nuveen Corporate Income November 2021 Target Term Fund JHB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,000
Closed -$94K 531
2021
Q3
$94K Hold
10,000
﹤0.01% 496
2021
Q2
$94K Hold
10,000
﹤0.01% 486
2021
Q1
$94K Hold
10,000
﹤0.01% 461
2020
Q4
$92K Hold
10,000
﹤0.01% 428
2020
Q3
$90K Hold
10,000
﹤0.01% 384
2020
Q2
$89K Hold
10,000
0.01% 383
2020
Q1
$86K Hold
10,000
0.01% 357
2019
Q4
$100K Hold
10,000
0.01% 412
2019
Q3
$99K Hold
10,000
0.01% 414
2019
Q2
$99K Hold
10,000
0.01% 407
2019
Q1
$98K Hold
10,000
0.01% 402
2018
Q4
$89K Hold
10,000
0.01% 350
2018
Q3
$95K Buy
+10,000
New +$96.1K 0.01% 553

Wilbanks Smith & Thomas Asset Management's JHB Position: Q4 2021 in Review

Wilbanks Smith & Thomas Asset Management sold out of Nuveen Corporate Income November 2021 Target Term Fund (JHB) in Q4 2021, closing a stake of 10,000 shares — an estimated $94K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in JHB in Q3 2018 and held it in 13 quarters. The position peaked at $100K in Q4 2019. 0 funds tracked by Wall St. Rank hold JHB as of Q4 2021.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Nuveen Corporate Income November 2021 Target Term Fund position as of Q4 2021 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 10,000 Nuveen Corporate Income November 2021 Target Term Fund shares in Q4 2021, an estimated $94K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Nuveen Corporate Income November 2021 Target Term Fund in Q3 2018 and held it in 13 quarters.
  • Wilbanks Smith & Thomas Asset Management's Nuveen Corporate Income November 2021 Target Term Fund position peaked at $100K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Nuveen Corporate Income November 2021 Target Term Fund as of Q4 2021.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2021, filed 8 Feb 2022.